Total Payments
$9,716
2024 Payments
$1,489
Companies
51
Transactions
560
Medicare Patients
1,589
Medicare Billing
$311,413
Payment Breakdown by Category
Food & Beverage$9,704 (99.9%)
Education$11.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,704 | 559 | 99.9% |
| Education | $11.71 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,385 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $943.10 | 48 | $0 (2024) |
| Novo Nordisk Inc | $820.27 | 44 | $0 (2024) |
| ABBVIE INC. | $776.72 | 44 | $0 (2024) |
| PFIZER INC. | $558.28 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $513.96 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $411.89 | 21 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $388.37 | 23 | $0 (2024) |
| Amarin Pharma Inc. | $348.88 | 19 | $0 (2021) |
| Amgen Inc. | $309.38 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,489 | 73 | PFIZER INC. ($213.66) |
| 2023 | $1,761 | 89 | Lilly USA, LLC ($326.20) |
| 2022 | $1,813 | 105 | Lilly USA, LLC ($289.59) |
| 2021 | $2,094 | 131 | Lilly USA, LLC ($324.13) |
| 2020 | $1,213 | 74 | Lilly USA, LLC ($204.65) |
| 2019 | $492.89 | 32 | Novo Nordisk Inc ($200.24) |
| 2018 | $495.94 | 30 | GlaxoSmithKline, LLC. ($166.11) |
| 2017 | $357.96 | 26 | GlaxoSmithKline, LLC. ($126.91) |
All Payment Transactions
560 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $67.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardio-renal | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.62 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: PAIN | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: PAIN | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: PAIN | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Obesity | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: PAIN | ||||||
| 08/21/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Immunology | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Cardio-renal | ||||||
| 08/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.88 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 391 | 929 | $171,830 | $77,612 |
| 2022 | 7 | 407 | 871 | $166,360 | $76,189 |
| 2021 | 7 | 372 | 891 | $167,707 | $84,449 |
| 2020 | 10 | 419 | 934 | $140,575 | $73,164 |
Total Patients
1,589
Total Services
3,625
Medicare Billing
$311,413
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 718 | $143,600 | $60,183 | 41.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $11,950 | $8,550 | 71.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 39 | $7,800 | $5,181 | 66.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $6,400 | $3,371 | 52.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 19 | $570.00 | $165.51 | 29.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $750.00 | $157.92 | 21.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 38 | $760.00 | $3.19 | 0.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 673 | $133,810 | $56,578 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $8,750 | $6,320 | 72.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $7,000 | $4,042 | 57.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 29 | $5,775 | $3,978 | 68.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 58 | $7,050 | $2,729 | 38.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $3,525 | $2,374 | 67.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 15 | $450.00 | $167.12 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 187 | 649 | $122,450 | $57,189 | 46.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 46 | 78 | $15,400 | $10,655 | 69.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 18 | 24 | $6,425 | $4,402 | 68.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $6,182 | $4,028 | 65.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 64 | $7,450 | $3,813 | 51.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $6,200 | $2,536 | 40.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $3,600 | $1,825 | 50.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 214 | 618 | $92,950 | $44,298 | 47.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 39 | 51 | $8,975 | $5,339 | 59.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 94 | $9,400 | $4,526 | 48.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 26 | $6,500 | $4,338 | 66.7% |
About Dr. Benjamin Devries, DO
Dr. Benjamin Devries, DO is a Family Medicine healthcare provider based in Clearwater, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1164738159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Devries, DO has received a total of $9,716 in payments from pharmaceutical and medical device companies, with $1,489 received in 2024. These payments were reported across 560 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($9,704).
As a Medicare-enrolled provider, Devries has provided services to 1,589 Medicare beneficiaries, totaling 3,625 services with total Medicare billing of $311,413. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Clearwater, FL
- Active Since 08/27/2010
- Last Updated 01/07/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164738159
Products in Payments
- NURTEC ODT (Drug) $782.62
- TRELEGY ELLIPTA (Drug) $711.06
- EMGALITY (Drug) $627.58
- XIFAXAN (Drug) $406.67
- Ozempic (Drug) $351.13
- Vascepa (Drug) $348.88
- VRAYLAR (Drug) $331.37
- MOUNJARO (Drug) $312.48
- TRULICITY (Drug) $312.04
- UBRELVY (Drug) $294.19
- JARDIANCE (Drug) $271.33
- FARXIGA (Drug) $253.96
- QULIPTA (Drug) $213.79
- XARELTO (Drug) $198.44
- ELIQUIS (Drug) $181.27
- Aimovig (Biological) $180.26
- Tresiba (Drug) $151.98
- ENTRESTO (Drug) $151.53
- FREESTYLE LIBRE 2 (Device) $142.40
- Kerendia (Drug) $123.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clearwater
Dr. David Hicks, D.o, D.O
Family Medicine — Payments: $39,587
Family Medicine $39,587
Dr. Jon Beasley, M.d, M.D
Family Medicine — Payments: $22,109
Family Medicine $22,109
Dr. Alex Garrido-Zambrano, M.d, M.D
Family Medicine — Payments: $22,044
Family Medicine $22,044
Dr. Fred Brennan, Do, DO
Family Medicine — Payments: $21,434
Family Medicine $21,434
Dr. Timothy Light, D.o, D.O
Family Medicine — Payments: $9,611
Family Medicine $9,611
Dr. William Alvarez, D.o, D.O
Family Medicine — Payments: $8,961
Family Medicine $8,961